AzTrials
AzTrials

Postoperative PainPhase 3NCT01378819

3-midline-ports Cholecystectomy

A Phase 3 study testing 3-midline-ports laparoscopic cholecystectomy in people with Postoperative Pain, run by Universidad Miguel Hernandez de Elche.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The 3-midline-ports technique is a safety approach and associates lower postoperative pain, when compared with the standard "French" technique. Read more about this study

Who is it for?
Any age
Conditions the study is for
Postoperative Pain
What is being tested?
3-midline-ports laparoscopic cholecystectomy
Type of treatment
Surgery or procedure
How many people
100 participants
Where
No sites listed yet
Study dates
Feb 2010to Dec 2010
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients undergoing elective cholecystectomy for symptomatic gallstones.

Who cannot join

  • Diagnosis of acute cholecystitis

About this study

Official title: Three Ports Placed in the Line Alba of the Abdomen (3-midline-ports Technique): an Alternative Approach for Laparoscopic Cholecystectomy

The 3-midline-ports technique is a safety approach and associates lower postoperative pain, when compared with the standard "French" technique.

Read the detailed description

The patients will be randomized into 2 groups: those patients undergoing laparoscopic cholecystectomy following the "French" technique (Group 1) and those ones undergoing the 3-midline-ports approach (Group 2).

Being tested
3-midline-ports laparoscopic cholecystectomy
Keywords
laparoscopic cholecystectomy, Postoperative pain
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3-midline-ports laparoscopic cholecystectomyProcedure or surgery

    The laparoscopic cholecystectomy will be performed through 3 ports placed in the line alba.

  • 3-midline-ports laparoscopic cholecystectomyProcedure or surgery

    Laparoscopic cholecystectomy will be performed through 3 ports placed in the line alba.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain

    The postoperative pain will be investigated 24 hours after surgery

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2011 (estimated)
  2. Study startFeb 2010
  3. Primary completionDec 2010
  4. Study completionDec 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01378819
Sponsor's protocol ID
UMH
Status last verified
Feb 2010
First submitted
20 Jun 2011
Last updated
22 Jun 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing 3-midline-ports laparoscopic cholecystectomy in people with Postoperative Pain, run by Universidad Miguel Hernandez de Elche.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2011. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in